sar425899 sanofi glp-1 glucagon dual agonist Media Centre Effects on weight loss and

Work with your clinician to optimize the dose ramp, slow the weekly loss rate if feasible , and screen for correctable deficiencies

Its one of the oldest weight loss medications available, usually prescribed short-term (typically up to 12 weeks)

The insulinotropic effect of DPP-4 inhibitors explains the phenomenon that this class increasingly is replacing the use of sulfonylureas as insulin releasing agents

KFF Health Tracking Poll: The publics views on new prescription weight-loss drugs. October 2024

However, the studies often take a broad landscape, lacking a detailed analysis of the specific roles and limitations of GLP-1RAs across different pain conditions